Ad is loading...
MENU

PIRS Pieris Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of an anticalin-brand protein technology

Industry Biotechnology
PIRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
PIRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PIRS is expected to report earnings to fall 320.00% to -10 cents per share on November 08

Pieris Pharmaceuticals PIRS Stock Earnings Reports
Q3'23
Est.
$-0.11
Q2'23
Beat
by $0.21
Q1'23
Est.
$-0.18
Q4'22
Beat
by $0.12
Q3'22
Beat
by $0.03
The last earnings report on August 03 showed earnings per share of 5 cents, beating the estimate of -15 cents. With 6.41K shares outstanding, the current market capitalization sits at 21.01M.
A.I. Advisor
published General Information

General Information

a developer of an anticalin-brand protein technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 246-8998
Employees
50
Web
https://www.pieris.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARR18.810.09
+0.48%
ARMOUR Residential REIT
TS37.000.04
+0.11%
Tenaris S A
NWFL30.84-0.29
-0.93%
Norwood Financial Corp
MAN61.70-1.45
-2.30%
ManpowerGroup
SPRB0.49-0.03
-5.83%
Spruce Biosciences

PIRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PIRS has been closely correlated with BPTSY. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if PIRS jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PIRS
1D Price
Change %
PIRS100%
-0.52%
BPTSY - PIRS
89%
Closely correlated
-19.43%
FATE - PIRS
51%
Loosely correlated
-2.88%
MDGL - PIRS
39%
Loosely correlated
-4.66%
CYTK - PIRS
38%
Loosely correlated
-8.19%
AXON - PIRS
36%
Loosely correlated
-0.86%
More